---
layout: post
title: "Panray Corp. Sub Ormont Drug and Chemical Co., Inc., et al.; Withdrawal of Approval of Three New Drug Applications"
date: 2026-02-05 18:59:56 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-15629
original_published: 2022-07-22 00:00:00 +0000
significance: 8.00
---

# Panray Corp. Sub Ormont Drug and Chemical Co., Inc., et al.; Withdrawal of Approval of Three New Drug Applications

**Published:** February 05, 2026 18:59 UTC
**Source:** Federal Register
**Original Published:** July 22, 2022 00:00 UTC
**Document Number:** 2022-15629

## Summary

The Food and Drug Administration (FDA) is withdrawing approval of three new drug applications (NDAs) from multiple holders of those NDAs. The basis for the withdrawal is that these NDA holders have repeatedly failed to file required annual reports for the identified NDAs.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/07/22/2022-15629/panray-corp-sub-ormont-drug-and-chemical-co-inc-et-al-withdrawal-of-approval-of-three-new-drug)
- API: https://www.federalregister.gov/api/v1/documents/2022-15629

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
